Best Ways to Prepare for a Healthcare Investing Seat

To prepare effectively for a healthcare investing seat, especially in Late-Stage Biotech, Life Sciences, and MedTech, here are some actionable recommendations based on the most helpful WSO content:

1. Understand the Industry Fundamentals

• Clinical Trial Processes & Regulatory Environment: Familiarize yourself with the stages of clinical trials (Phase I, II, III, and IV) and the FDA approval process. This is critical for evaluating biotech and life sciences companies.
• Key Trends: Stay updated on the latest trends in biotech and MedTech through resources like FierceBiotech, FiercePharma, and Biospace. These publications provide insights into industry developments and innovations.

2. Leverage Equity Research Reports

• Access equity research reports and primers from major investment banks. These reports often provide a framework for understanding valuation methodologies and market dynamics.
• Analyze multiple equity research models to identify divergent assumptions and develop your own perspective on valuation and fundamentals.

3. Build a Knowledge Base

• Scientific Papers & Clinical Data: Read scientific papers and clinical trial data to understand the technical aspects of the companies you’ll be evaluating.
• Investor Presentations & SEC Filings: Review these documents to grasp company strategies, financials, and growth prospects. Use tools like Evaluate Pharma for additional insights.

4. Network with Industry Professionals

• Connect with junior equity research professionals or alumni in the healthcare space on LinkedIn. They can provide valuable insights and resources.
• Seek out friends or contacts on the buyside in biotech for guidance and access to resources.

5. Develop Stock Pitches

• Create a few well-researched stock pitches in the biotech or MedTech space. This will help you practice analyzing companies and articulating investment theses.
• Focus on identifying key drivers of value, such as clinical trial success, regulatory approvals, and market potential.

6. Learn Valuation Techniques

• Study valuation methodologies specific to biotech and MedTech, such as discounted cash flow (DCF) models, risk-adjusted NPV (rNPV), and comparable company analysis.
• Practice building your own models using SEC filings, investor presentations, and publicly available data.

7. Be Proactive

• Compile your research and insights into a presentation or document. Share it with your superior or mentor to demonstrate your initiative and understanding of the space.
• Treat this preparation as part of your job. Proactivity and hustle are highly respected in the industry.

8. Recommended Resources

• External resources: FierceBiotech, FiercePharma, Medscape, Axios Vitals, and Bain’s Global Healthcare Private Equity and Corporate M&A reports.
• Books: Consider reading Kolchinsky’s book on the biotech industry for a deeper understanding of its dynamics.

By focusing on these areas, you’ll be better equipped to navigate the nuances of healthcare investing and identify what truly matters in your investment analyses.

Sources: Biotech finance: from IB to VC / HF to funded startup, How Do I Get Smart in Biotechnology Space?, Biotech finance part 2: valuation methodologies and modeling considerations